Caplin Point Laboratories Ltd
NSE:CAPLIPOINT

Watchlist Manager
Caplin Point Laboratories Ltd Logo
Caplin Point Laboratories Ltd
NSE:CAPLIPOINT
Watchlist
Price: 2 500.65 INR -1.48% Market Closed
Market Cap: 190.1B INR
Have any thoughts about
Caplin Point Laboratories Ltd?
Write Note

EV/EBIT
Enterprise Value to EBIT

33.5
Current
15.8
Median
17
Industry
Higher than median
Higher than industry value

Enterprise Value to EBIT (EV/EBIT) ratio is a valuation multiple that compares the value of a company, debt included, to the company’s earnings before interest and taxes (EBIT). Considered one of the most frequently used multiples for comparisons among companies, the EV/EBIT multiple relies on operating income as the core driver of valuation.

EV/EBIT
33.5
=
Enterprise Value
181.3B INR
/
EBIT
5.4B INR
All Countries
Close
EBIT Growth EV/EBIT to Growth
IN
Caplin Point Laboratories Ltd
NSE:CAPLIPOINT
Average EV/EBIT: 1 813.4
33.5
20%
1.7
JP
N
Nichi-Iko Pharmaceutical Co Ltd
TSE:4541
Negative Multiple: -5 046 864.6 N/A N/A
US
Eli Lilly and Co
NYSE:LLY
52.6
46%
1.1
UK
Dechra Pharmaceuticals PLC
LSE:DPH
17 702.3
98%
180.6
DK
Novo Nordisk A/S
CSE:NOVO B
23.1
22%
1
US
Johnson & Johnson
NYSE:JNJ
14.9
9%
1.7
US
Merck & Co Inc
NYSE:MRK
12.5
98%
0.1
CH
Roche Holding AG
SIX:ROG
11.8
9%
1.3
UK
AstraZeneca PLC
LSE:AZN
253.9
32%
7.9
CH
Novartis AG
SIX:NOVN
13.2
17%
0.8
US
Pfizer Inc
NYSE:PFE
15.9
19%
0.8

EV/EBIT Forward Multiples

Forward EV/EBIT multiple is a version of the EV/EBIT ratio that uses forecasted EBIT for the EV/EBIT calculation. 1-Year, 2-Years, and 3-Years forwards use EBIT forecasts for 1, 2, and 3 years ahead, respectively.

1-Year Forward
EV/EBIT
26.7
2-Years Forward
EV/EBIT
23
3-Years Forward
EV/EBIT
21.2